Clinical Trial Update: Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 safety study evaluating darinaparsin in combination with CHOP for lymphoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Darinaparsin (darinaparsin)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Vincristine (vincristine)

Snippet

Sponsor: Alaunos Therapeutics | Conditions: Lymphoma | Phase 1 | Status: WITHDRAWN